Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | RARE | IMVT | ||
| Company | Crispr Therapeutics Ag | Ultragenyx Pharmaceu | Immunovant Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.21 | 46.02 | 26.43 | ||
| High | 47.21 | 47.14 | 26.78 | ||
| Low | 45.51 | 45.90 | 25.90 | ||
| Last | 46.29 | 46.02 | 26.54 | ||
| Change | -0.97 | -0.38 | +0.37 | ||
| % Change | -2.05% | -0.82% | +1.41% | ||
| Volume | 2,093,700 | 525,600 | 645,600 | ||
| 20-Day Average Volume | 1,903,150 | 978,345 | 853,850 | ||
| Previous Close | 47.26 | 46.40 | 26.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 49.18 | 49.45 | 28.90 | ||
| 20-Day Raw Stochastic | 5.75% | 24.11% | 25.77% | ||
| 20-Day Relative Strength | 44.77% | 36.18% | 40.78% | ||
| Weighted Alpha | -34.37 | +8.75 | -24.58 | ||
| Today's Opinion | 80% Sell | 24% Sell | 88% Sell | ||
| Previous Opinion | 80% Sell | 24% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Sell | 48% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.20% since 11/14/24 | -3.40% since 11/14/24 | -5.38% since 11/14/24 | ||
| Low | 45.51 on 11/21/24 | 43.04 on 11/18/24 | 24.61 on 11/19/24 | ||
| High | 48.44 on 11/15/24 | 48.11 on 11/15/24 | 28.04 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -4.58% since 10/21/24 | -15.50% since 10/21/24 | -9.64% since 10/21/24 | ||
| Low | 45.44 on 10/23/24 | 43.04 on 11/18/24 | 24.61 on 11/19/24 | ||
| High | 59.07 on 11/11/24 | 56.38 on 10/23/24 | 32.10 on 11/06/24 | ||
| 3-Month | |||||
| %Chg | -7.40% since 08/21/24 | -19.33% since 08/21/24 | -18.24% since 08/21/24 | ||
| Low | 43.42 on 09/06/24 | 43.04 on 11/18/24 | 24.61 on 11/19/24 | ||
| High | 59.07 on 11/11/24 | 60.37 on 09/16/24 | 34.47 on 09/06/24 | ||
| 6-Month | |||||
| %Chg | -15.47% since 05/21/24 | +13.41% since 05/21/24 | -12.41% since 05/21/24 | ||
| Low | 43.42 on 09/06/24 | 37.02 on 06/18/24 | 24.61 on 11/19/24 | ||
| High | 67.88 on 06/13/24 | 60.37 on 09/16/24 | 34.47 on 09/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,033,782 | 4,284,762 | 3,841,364 | ||
| Shares Outstanding, K | 85,353 | 92,344 | 146,785 | ||
| Annual Sales | 371,210,000 | 434,250,000 | 0 | ||
| Annual Net Income | -153,610,000 | -606,640,000 | -259,340,000 | ||
| Last Quarter Sales | 600,000 | 139,490,000 | 0 | ||
| Last Quarter Net Income | -85,940,000 | -133,520,000 | -109,120,000 | ||
| 60-Month Beta | 1.67 | 0.58 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.01 on 11/05/24 | -1.40 on 11/05/24 | -0.74 on 11/07/24 | ||
| Latest Earnings Date | 11/04/24 | 11/05/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||